Buy This Ophthalmology Stock But Sell This One, Says Bernstein Analyst: 'Innovation Is Key' Innovation and digitalization have been in focus among ophthalmology majors. Vision is the most ...

In a report released today, Graham Doyle from UBS maintained a Hold rating on Carl Zeiss Meditec (0DHC – Research Report), with a price target ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Carl Zeiss Meditec AG (ETR:AFX – Get Free Report)’s share price traded up 2.3% on Friday . The company traded as high as €47.00 ($48.45) and last traded at €46.56 ($48.00). Approximately 224,325 ...

Key Insights The projected fair value for Carl Zeiss Meditec is €77.77 based on 2 Stage Free Cash Flow to Equity ...

Over the last year, Carl Zeiss Meditec share price has been traded in a range of 76.93, hitting a high of 122.25, and a low of 45.32. It is classified as being part of the Medical Equipment subsector.

There's been a notable change in appetite for Carl Zeiss Meditec AG (ETR:AFX) shares in the week since its yearly report, with the stock down 15 ... to the €64.23 price target, showing that ...

One common approach is to try and... Most readers would already be aware that Carl Zeiss Meditec's (ETR:AFX) stock increased significantly by 19% over the... ZEISS Medical Technology will showcase ...

One common approach is to try and... Most readers would already be aware that Carl Zeiss Meditec's (ETR:AFX) stock increased significantly by 19% over the... ZEISS Medical Technology will showcase ...